Can an app help older leukemia patients track their health at home?
NCT ID NCT07597590
First seen Jun 25, 2026 · Last updated Aug 07, 2026 · Updated 3 times
Summary
This pilot study tests whether adults aged 65 and older with acute leukemia can use a digital platform to complete health questionnaires from home. Twenty participants will fill out surveys about their quality of life and symptoms on a tablet or phone, with results sent directly to their care team. The goal is to see if this approach is practical and whether it can improve follow-up care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Digital structured assessment (questionnaires via app)
- What this could lead to
- If successful, this could show that remote digital monitoring is practical for older leukemia patients, potentially improving follow-up care and quality of life tracking.
- What could go wrong
- This is a very small pilot study (20 people) with no control group, so results may not apply widely. Technical issues or patient difficulty with the app could limit success.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA ACUTE LYMPHOID LEUKEMIA (ALL) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario Central de Asturias (HUCA)
Oviedo, Principality of Asturias, 33011, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a targeted pill turn the tide against a bone marrow disorder?
- New Three-Drug cocktail aims to beat aggressive leukemia
- New cell therapy aims to supercharge Kids' immune cells after transplant
- Empowerment program shows promise for healthier habits in young leukemia patients
- New hope for tough blood cancers: experimental drug MGD024 enters human testing